Characteristics of Mediastinal Lymph Node With False Positive FDG PET/CT Results in Lung Cancer Staging : Relation With TB and Latent TB Infection

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01376856

Enrollment

Registered

2011-06-20

Start date

2011-06-30

Completion date

2011-11-30

Last updated

2013-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

mediastinal lymph node with false positive FDG PET/CT results in lung cancer staging

Brief summary

The purpose of this study is to analyze pathologic and radiologic characteristics of mediastinal lymph nodes with false positive FDG PET/CT results in lung cancer staging and assess relationship between false positive mediastinal lymph node and TB/latent TB.

Interventions

None listed

Study design

Observational model

CASE_CROSSOVER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 75 Years

Healthy volunteers

Inclusion criteria

* age 20-75, men and women * person who performed PET/CT and surgical biopsy of mediastinal lymph node for diagnosis of primary lung cancer of metastatic lung cancer

Exclusion criteria

* age \< 20 * person who don't agree with enrollment * illiterate * person who is diagnosed as active tuberculosis now * person who has history of hypersensitivity on PPD (tuberculin purified protein derivative) * pregnant woman * person who is treated as active tuberculosis

Design outcomes

Primary

Measure	Time frame
false positive rate of Mediastinal Lymph Node	3months

Countries

South Korea

Outcome results